Profile data is unavailable for this security.
About the company
FDC Limited is an India-based company, which is principally engaged in the business of manufacturing and trading of pharmaceutical products. The Company is specialized in manufacturing Oral Rehydration Solutions (ORS), energy drinks, antibiotics and ophthalmic therapies. Its products include Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen Sodium, Miconazole Nitrate, Timolol Maleate, Amoxycillin + Clavulanic Acid, Rupatadine Fumarate, Salbutamol Sulphate, Kaolin Light/ Pectin, among others. The Company’s product offerings cover an extensive range of categories, including anti-infectives, gastrointestinal treatments, ophthalmic, vitamins, minerals, dietary supplements, cardiovascular solutions, anti-diabetics, respiratory care, gynecology, dermatology and analgesics. Its various brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.
- Revenue in INR (TTM)20.78bn
- Net income in INR2.17bn
- Incorporated1940
- Employees6.86k
- LocationF D C Ltd142-148, S.V. Road, Jogeshwari (W)MUMBAI 400053IndiaIND
- Phone+91 2 226739100
- Fax+91 2 226300614
- Websitehttps://www.fdcindia.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gujarat Themis Biosyn Ltd | 1.59bn | 477.88m | 36.00bn | 221.00 | 75.32 | -- | 62.18 | 22.59 | 4.39 | 4.39 | 14.62 | -- | -- | -- | -- | 7,209,322.00 | -- | 30.70 | -- | 34.37 | 62.78 | 68.03 | 29.99 | 35.51 | -- | 55.73 | -- | -- | -11.20 | 12.12 | -17.56 | 15.55 | 104.61 | 24.95 |
| Senores Pharmaceuticals Ltd | 5.89bn | 1.02bn | 37.66bn | 194.00 | 36.49 | -- | 28.96 | 6.40 | 22.41 | 22.41 | 130.31 | -- | -- | -- | -- | 30,336,080.00 | -- | -- | -- | -- | 58.73 | -- | 17.48 | -- | -- | 5.94 | -- | -- | 85.64 | -- | 86.17 | -- | -- | -- |
| Innova Captab Ltd | 14.97bn | 1.32bn | 40.36bn | 1.95k | 30.49 | -- | 22.93 | 2.70 | 23.13 | 23.13 | 261.52 | -- | -- | -- | -- | 7,676,703.00 | -- | 10.02 | -- | 15.00 | 36.26 | 27.20 | 8.85 | 8.72 | -- | 12.45 | -- | -- | 15.02 | 27.21 | 35.95 | 35.69 | 109.94 | -- |
| Sun Pharma Advanced Research Co Ltd | 531.36m | -2.68bn | 44.45bn | 316.00 | -- | -- | -- | 83.65 | -8.26 | -8.26 | 1.64 | -- | -- | -- | -- | 1,681,519.00 | -- | -60.53 | -- | -129.98 | 54.57 | 77.17 | -504.20 | -168.34 | -- | -8.82 | -- | -- | -5.00 | -1.35 | 11.55 | -- | -28.16 | -- |
| Zota Health Care Ltd | 4.73bn | -726.58m | 48.48bn | 519.00 | -- | -- | -- | 10.25 | -23.98 | -23.98 | 157.24 | -- | -- | -- | -- | 9,108,992.00 | -- | -7.79 | -- | -10.57 | 57.22 | 42.02 | -15.34 | -8.01 | -- | -3.71 | -- | -- | 62.32 | 25.23 | -293.08 | -- | 49.40 | 0.00 |
| Supriya Lifescience Ltd | 7.35bn | 1.85bn | 57.15bn | 515.00 | 30.81 | -- | 27.05 | 7.77 | 23.05 | 23.05 | 91.47 | -- | -- | -- | -- | 14,280,700.00 | -- | 18.45 | -- | 21.63 | 72.33 | 59.62 | 25.19 | 25.45 | -- | 129.43 | -- | 3.59 | 22.11 | 17.45 | 57.80 | 20.69 | 45.94 | -- |
| F D C Ltd | 20.78bn | 2.17bn | 63.99bn | 6.86k | 29.53 | -- | 23.09 | 3.08 | 13.31 | 13.31 | 127.73 | -- | -- | -- | -- | 3,030,531.00 | -- | 11.35 | -- | 12.96 | 67.92 | 60.85 | 10.43 | 14.75 | -- | 47.92 | -- | 6.34 | 8.50 | 9.42 | -12.59 | 2.15 | 25.37 | -- |
| Shilpa Medicare Ltd | 14.32bn | 1.50bn | 64.84bn | 898.00 | 42.77 | -- | 24.20 | 4.53 | 7.75 | 7.75 | 73.87 | -- | -- | -- | -- | 15,945,910.00 | -- | 2.02 | -- | 2.61 | 70.47 | 60.07 | 10.48 | 5.17 | -- | 4.67 | -- | 9.89 | 11.71 | 7.22 | 145.63 | -12.90 | 16.09 | -- |
| Aarti Pharmalabs Ltd | 19.06bn | 2.40bn | 67.98bn | 2.16k | 28.35 | 3.32 | 20.40 | 3.57 | 26.45 | 26.45 | 210.27 | 225.75 | 0.6309 | 1.39 | 4.22 | 8,812,209.00 | 7.94 | -- | 10.54 | -- | 51.04 | -- | 12.58 | -- | 0.8706 | 9.62 | 0.2435 | -- | 14.17 | -- | 25.59 | -- | -- | -- |
| Akums Drugs and Pharmaceuticals Ltd | 41.08bn | 3.17bn | 72.09bn | 7.54k | 22.74 | 2.29 | 14.94 | 1.76 | 20.71 | 20.71 | 268.25 | 205.66 | 0.8712 | 3.69 | 4.85 | 5,450,531.00 | 6.86 | -- | 8.82 | -- | 41.18 | -- | 7.87 | -- | 3.18 | 4.98 | 0.0277 | -- | -1.44 | -- | 8,481.07 | -- | -- | -- |
| Sudeep Pharma Ltd | 6.17bn | 1.68bn | 74.66bn | -- | 43.37 | -- | 40.65 | 12.11 | 15.24 | 15.24 | 55.94 | -- | -- | -- | -- | -- | -- | -- | -- | -- | 63.01 | -- | 27.56 | -- | -- | 55.99 | -- | -- | 9.40 | -- | 4.19 | -- | -- | -- |
| Blue Jet Healthcare Ltd | 11.79bn | 3.52bn | 76.70bn | 491.00 | 21.76 | 6.11 | 20.53 | 6.50 | 20.32 | 20.32 | 68.01 | 72.39 | 0.8706 | 2.87 | 4.51 | 24,013,560.00 | 26.02 | -- | 31.72 | -- | 54.32 | -- | 29.89 | -- | 3.29 | 78.01 | 0.0162 | -- | 44.74 | -- | 86.38 | -- | -- | -- |
| Strides Pharma Science Ltd | 47.26bn | 5.11bn | 80.71bn | 3.30k | 15.78 | -- | 11.08 | 1.71 | 55.49 | 55.49 | 512.73 | -- | -- | -- | -- | 14,315,680.00 | -- | -0.6014 | -- | -1.09 | 59.34 | 50.33 | 11.23 | -1.06 | -- | 8.50 | -- | -- | 17.36 | 10.65 | 437.22 | 52.50 | 10.08 | -22.16 |
| Marksans Pharma Ltd | 28.03bn | 3.60bn | 84.99bn | 1.35k | 23.57 | -- | 18.52 | 3.03 | 7.96 | 7.96 | 61.92 | -- | -- | -- | -- | 20,780,450.00 | -- | 14.15 | -- | 17.41 | 56.77 | 51.56 | 12.90 | 14.58 | -- | 20.42 | -- | 7.77 | 20.46 | 18.25 | 21.32 | 26.60 | 23.73 | 51.57 |
| Jeena Sikho Lifecare Ltd | -100.00bn | -100.00bn | 89.22bn | 3.76k | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 32.29 | -- | 40.74 | -- | 92.07 | -- | 16.78 | -- | -- | -- | -- | 44.59 | 37.80 | 31.10 | 73.77 | 47.62 | -- |
| Procter & Gamble Health Ltd | 13.49bn | 2.93bn | 91.01bn | 1.33k | 31.04 | -- | 28.78 | 6.75 | 176.64 | 176.64 | 811.45 | -- | -- | -- | -- | 10,169,760.00 | -- | -- | -- | -- | 72.49 | -- | 21.76 | -- | -- | 806.81 | -- | -- | -- | -- | -- | -- | -- | -- |
Data as of Feb 12 2026. Currency figures normalised to F D C Ltd's reporting currency: Indian Rupee INR
7.43%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| ICICI Prudential Asset Management Co. Ltd. (Invt Mgmt)as of 31 Dec 2025 | 4.49m | 2.76% |
| Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 31 Dec 2025 | 4.28m | 2.63% |
| Dimensional Fund Advisors LPas of 08 Jan 2026 | 1.11m | 0.68% |
| Tata Asset Management Pvt Ltd.as of 31 Dec 2025 | 645.62k | 0.40% |
| Bandhan AMC Ltd.as of 31 Dec 2025 | 447.00k | 0.28% |
| SSgA Funds Management, Inc.as of 08 Jan 2026 | 435.77k | 0.27% |
| BlackRock Fund Advisorsas of 08 Jan 2026 | 261.86k | 0.16% |
| BlackRock Advisors (UK) Ltd.as of 09 Jan 2026 | 183.24k | 0.11% |
| Motilal Oswal Asset Management Co. Ltd.as of 31 Dec 2025 | 170.36k | 0.11% |
| ITI Asset Management Ltd. (India)as of 31 Dec 2025 | 76.18k | 0.05% |
More ▼
Data from 30 Sep 2025 - 30 Jan 2026Source: FactSet Research Systems Inc.
